Home > PE Ratio > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
PE (Price/Earnings) Ratio

The Current P/E Ratio of MEDICAMEN BIOTECH is 98.76.

Share Price ₹449.1Nov 19,2024
Market Cap ₹570.4 Cr
Earnings-TTM₹5.8 CrTTM-Consolidated Results
Price/Earnings98.76xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MEDICAMEN BIOTECH is calculated as :

Current Market Cap [ ₹570.4 Cr] as on Nov 19,2024

(/) Earnings [ ₹5.8 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 98.76x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 98.76 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.

Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH


PE Ratio Performance Analysis for MEDICAMEN BIOTECH

- MEDICAMEN BIOTECH 's latest p/e ratio is 98.76x.

- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 46.16x.

- MEDICAMEN BIOTECH 's operated at median p/e ratio of 52.79x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2023 at 56.31x.

- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2020 of 16.61x.


How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MEDICAMEN BIOTECH 5.7898.76570.4
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.30426,518.0
CIPLA LTD4,485.2226.39118,368.0
DR REDDYS LABORATORIES LTD5,406.8018.4399,671.4
ZYDUS LIFESCIENCES LTD4,298.9022.1095,013.6
DIVIS LABORATORIES LTD1,836.0086.40158,636.0
MANKIND PHARMA LTD2,124.8648.13102,273.0
TORRENT PHARMACEUTICALS LTD1,802.0058.31105,072.0
LUPIN LTD2,651.9435.1593,214.9
AUROBINDO PHARMA LTD3,598.8319.6970,869.4
ABBOTT INDIA LTD1,284.6644.9057,681.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.43x
Max industry PE 98.76x
Median industry PE 38.30x
Average industry PE 45.14x



You may also like the below Video Courses